Purpose: Blood oxygen level-dependent (BOLD) MRI has been effectively used to monitor changes in renal oxygenation. However, R2* (or T2*) is not specific to blood oxygenation and is dependent on other factors. This study investigates the use of a statistical model that takes these factors into account and maps BOLD MRI measurements to blood pO2. Methods: Spin echo and gradient echo images were obtained in six Sprague-Dawley rats and R2 and R2* maps were computed. Measurements were made at baseline, post-nitric oxide synthase inhibitor (L-NAME), and post-furosemide administration. A simulation of each region was performed to map R2 0 (computed as R2*-R2) to blood pO2. Results: At baseline, blood pO2 in the outer medulla was 30.5 6 1.2 mmHg and 51.9 6 5.2 mmHg in the cortex, in agreement with previous invasive studies. Blood pO2 was found to decrease within the outer medulla following L-NAME (P < 0.05) and increase after furosemide (P < 0.05). Blood pO2 in the cortex increased following furosemide (P < 0.05). Conclusions: Model-derived blood pO2 is sensitive to pharmacological challenges, and baseline pO2 is comparable to literature values. Reporting pO2 instead of R2* could lead to a greater clinical impact of renal BOLD MRI and facilitate the identification of hypoxic regions. Magn Reson Med 78:297-302,
INTRODUCTION
Blood oxygen level-dependent (BOLD) MRI is a noninvasive method that is sensitive to regional oxygen saturation of hemoglobin (SHb). It is currently the only noninvasive method available to evaluate relative renal oxygenation status and it can be readily applied in humans (1) . Previous studies have established BOLD MRI as an effective and sensitive method for monitoring changes in both preclinical models (2) (3) (4) and in humans (1, 5, 6) . However, translation of BOLD MRI to the clinic remains challenging (7) .
Two key limitations are suspected to play a role. One is the use of small region of interest (ROI) analysis. Small ROIs are subjective and may be limited by the available contrast between regions, which can be compromised under certain disease states (8) . There have been recent developments to mitigate this issue by using methods that analyze the entire renal parenchyma (9) (10) (11) (12) . Another limitation of BOLD MRI is the inability to directly compare the measurements between regions due to the fact that the R2* (or T2*) measurements, the transverse relaxation rate, depend on more parameters than just the magnetic susceptibility of deoxygenated hemoglobin. These parameters include the spin-spin relaxation rate (R2), regional blood volume, and hematocrit (HCT). Each of these may vary significantly between individuals, even regionally within a kidney, and with disease. These dependencies limit the ability to directly compare R2* measurements between kidney regions or measurements between groups. For example, the inner medulla in rodents consistently has a lower R2* than the cortex and would be viewed as having a higher blood pO2 level based on the usual BOLD interpretation. However, invasive measurements show that the inner medulla has the lowest pO2 (13) . This discrepancy is thought to be due to the lower blood volume and lower hematocrit of the inner medulla (14) . Furthermore, R2* cannot directly indicate hypoxic regions. An increased R2* may show a region with decreased oxygen availability due to the measured decrease in SHb, but it does not indicate whether the tissue's oxygen demand is being met. It is known that certain regions of the kidney are operating on the verge of hypoxic conditions, and the ability to convert R2* measurements to blood pO2 could provide a means of comparing these regions to pO2 levels that may be at risk of hypoxic damage.
Recent work has demonstrated the feasibility of mapping BOLD MRI measurements to blood pO2 (15) . The method is based on R2 0 (R2*-R2) as opposed to the conventional R2* parameter. Using Monte Carlo simulation, the model estimates R2 0 for a given SHb value, resulting in a lookup table from R2 0 to SHb for each tissue type based on regional parameters. In this preliminary study, we apply this model to a small number of rats to find baseline blood pO2 values and how they compare to invasive measurements in the literature, further evaluating the sensitivity to changes in pO2 following pharmacological maneuvers.
METHODS

Animals
The Institutional Animal Care and Use Committee approved all procedures and protocols in this study. Six male Sprague-Dawley rats (Charles River, Chicago, IL), weighing 402 6 20 g, were used in this study. Rats had free access to water and food prior to being anesthetized. All procedures were conducted under anesthesia using Inactin (thiobutabarbital sodium, 100 mg/kg i.p., SigmaAldrich, St. Louis, MO). A catheter (PE-50 tubing) was placed in the femoral vein of each rat for administration of nitric oxide synthase inhibitor (L-NAME) and furosemide (Sigma-Aldrich, St. Louis, MO). These drugs were used to modulate renal perfusion and/or oxygenation. Each drug was administered at a concentration of 10 mg/ kg body weight into the femoral vein as a bolus.
Each animal's tail was connected to a peripheral oximeter to monitor any systemic changes in global blood SHb (3150 MRI Patient Monitor; Invivo Research Inc., Invivo Corp., Gainesville, FL). Measurements were recorded every 5 minutes.
MRI
All experiments were performed on a 3-telsa whole body scanner (Magnetom Verio, Siemens Healthcare, Erlangen, Germany), equipped with high-performance gradient coils (45 mT/m maximum gradient strength, 200 mT/m per milliseconds slew rate). Rats were placed in a right decubitus position such that the kidneys were in the middle of a knee coil (8-channel Knee Coil, Siemens Healthcare, Erlangen, Germany). Each rat was then positioned within the MRI scanner such that the middle of the kidney being examined was at the isocenter of the magnet.
Imaging was performed in three stages: baseline, post-L-NAME, and post-furosemide administration. In two additional animals, data was obtained at baseline and repeated after administration of furosemide.
Analysis
Following MRI data acquisition, ROIs were manually defined in the cortex (region furthest from the renal pelvis, containing majority of glomeruli) and the outer medulla (outer portion of the closest region to renal FIG. 1. MRI protocol. The MRI data acquisition was performed in three stages: baseline, L-NAME, and furosemide. Each MRI stage consisted of three repetitions of alternating mGRE and SE acquisitions. L-NAME, nitric oxide synthase inhibitor; mGRE, multiple gradient recalled echo sequence; SE, spin echo. pelvis, borders cortex) of each kidney. A suite of custom image-processing software written in Python was used for the analysis (Python 2.7, NumPy 1.10, SciPy 0.16.1). R2* maps were created from the 12 echoes acquired by the mGRE sequences using a linear least squares fitting method, with regions near large susceptibility artifacts removed using thresholding (9) . R2 maps were created from the eight echoes acquired by the SE sequences using a linear least squares fitting method. As each MRI stage acquired three pairs of mGRE and SE acquisitions, the computed maps were averaged over these repetitions. ROIs for both regions were applied to the R2* and R2 maps, and the mean of each was found. R2 0 was calculated by subtracting the R2 mean from the R2* mean for each region.
A statistical model was used to estimate SHb and blood pO2 of each region (15) . The model simulates the BOLD signal by modeling blood vessels as randomly oriented cylinders within a voxel and red blood cells as spheres. At the start of the simulation, protons diffuse through the voxel and accumulate different phases, leading to a signal decay that is sensitive to the oxygen saturation of hemoglobin. The model was used to establish a relationship between SHb and R2 0 (Fig. 2a) . Blood pO2 was estimated from SHb using the oxyhemoglobin dissociation curve (Fig. 2b) . The following parameters were assumed for each region: cortex (vascular fraction: 0.27, hematocrit: 0.4, extravascular diffusion coefficient: 1.45, intravascular diffusion coefficient: 1, average vesicle radius: 10 (um)) and outer medulla (vascular fraction: 0.18, hematocrit: 0.25, extravascular diffusion coefficient: 1.04, intravascular diffusion coefficient: 1, average vesicle radius: 10 (um)) (16) (17) (18) .
Statistical Analysis
Statistically significant changes were assessed between each sequential stage within each region. Cohen's d was used to assess the magnitude of the change, and Wilcoxon's signed-rank test was used to assess the statistical significance. Although the range of d values depends on the experiment, a value of 0.8 or greater is generally considered a large effect (9, 19) . P values are reported with each test as well, values below 0.05 are considered statistically significant.
RESULTS
Our estimates for SHb and blood pO2 showed regional responses to L-NAME and furosemide. Figures 3a-d show boxplots for each region at each of the three stages for estimated R2, R2*, SHb, and blood pO2, respectively. At baseline, blood pO2 in the outer medulla was found   FIG. 3 . Box-whisker plots for R2 (a), R2* (b), SHb (c), and blood pO2 (d). The two regions assessed are shown (cortex and outer medulla). Each region shows three time points at which MRI was assessed: baseline, post-L-NAME, post-furosemide. L-NAME, nitric oxide synthase inhibitor; SHb, oxygen saturation of hemoglobin.
to be 30.5 6 1.2 mmHg and 51.9 6 5.2 mmHg in the cortex.
Statistically significant changes were observed in the outer medulla following L-NAME and furosemide. In the cortex, the change from L-NAME to furosemide was significant as well. Figure 4 .b is the summary of the mean pO2 values for all rats at each time point within the stages. Figure 5 shows the relative values of R2, R2*, and blood pO2 in three spatial locations of the rat kidney. The differences observed in blood pO2 are consistent with prior data based on invasive measurements.
No significant changes in peripheral SHb were found during the experiment in any of the rats (data not shown).
In the two additional rats given just furosemide, the pO2 change in the outer medulla was from 29.1 6 2.0 to 31.2 6 0.04 mmHg and in the cortex from 48.1 6 2.5 to 53.1 6 2.2 mmHg.
DISCUSSION
Our data supports the feasibility of applying this quantitative model to estimate renal blood pO2 based on BOLD MRI data acquisitions in rat kidneys, where there is a great amount of literature (13, 20, 21) . At baseline, blood pO2 in the outer medulla was found to be 30.5 6 1.2 mmHg and 51.9 6 5.2 mmHg in the cortex, which is in line with previously measured values using microelectrodes (20) . However, because microelectrode studies are unable to differentiate between capillary blood pO2 and tissue pO2, the measurement is not entirely specific to the measurements reported here. Future studies that can differentiate between the two are necessary, for example, using phosphometric measurements (22) .
L-NAME acts as a vasoconstrictor in the renal circulatory system. Our results show that blood pO2 decreases following administration of L-NAME, as expected (23) . The outer medulla showed a significant decrease in pO2 (P ¼ 0.028; d ¼ 3.60). Although the cortex showed The relative values of R2, R2*, and blood pO2 between each region are illustrated here. At baseline, the mean and standard deviations of are shown for each region for R2* and blood pO2 measurements. The relative R2* values are hard to interpret because the low R2* in the inner medulla would indicate higher blood oxygenation. However, it is well known that inner medulla has the least pO2 (22) . Using the same parameters as the outer medulla, the estimated pO2 appears to be closer to the outer medulla. The conversion to pO2 also facilitates identifying regions that are hypoxic, for example, compared to systemic venous pO2.IM, inner medulla; OM, outer medulla.
downward shifts as well in blood pO2, it was not statistically significant.
Furosemide acts to increase renal pO2 by inhibiting sodium reabsorption in the medullary thick ascending limb and is generally confined to the medulla region (21) . Because L-NAME is known to act for up to 2 hours (24), the observed postfurosemide response is really a combined response to L-NAME and furosemide. In this preliminary study, our focus was to demonstrate sensitivity to hemodynamic changes and not to study the exact effects of each of the drugs in isolation; thus, we consider this to be an acceptable compromise. From the results, we see that a significant increase in pO2 is observed in both regions, with the larger change resulting in the outer medulla (P ¼ 0.046; d ¼ -1.40). However, in two additional rats given just furosemide, an increase in pO2 was observed in the outer medulla consistent with prior reports (21) . The cortex also showed an increase, probably due to the fact that the cortical portion of the nephrons is a part of Henle's loops at the cortico-medullary junction, which is consistent with a previous study (25) .
Changes in R2* are often discussed as being a measure of changes in oxygenation or degree of hypoxia. However, as shown in Figure 5 , the relative values of R2* do not strictly indicate the relative oxygenation in different regions. For the same reason, it is also not possible to define a threshold value of R2* above which the tissue can be assumed to be hypoxic. However, by taking the differences in physiological parameters (e.g., HCT and blood volume) between the two regions into account, the estimated blood pO2 shows the well accepted gradient between the cortex and outer medulla. Further, pO2 of the inner medulla is lower than the cortex, even though it is not lower than the outer medulla, as expected (13) . This is probably due to the lack of data on relative values of blood volume and HCT, specifically for the inner medulla. For this preliminary study, we assumed the same values for the entire medulla.
The primary mechanism for transporting O2 molecules in blood plasma to the mitochondria is diffusion (26) . The difference in blood pO2 and mitochondrial pO2 is what establishes this diffusion gradient and the maximum amount of O2 that can be extracted from the blood in a given amount of time. Although it is difficult to determine mitochondrial pO2 (27) , one study has estimated it to be in the range of 30 to 40 mm Hg (28) . Thus, if blood pO2 is at or below this range, the oxygen will not be transported to the cells by diffusion, and the tissue will be at risk of hypoxic injury. Interestingly, the systemic venous pO2 is also about 40 mmHg (29) .
The relative pO2 values in Figure 5 suggest that the cortex is normoxic, whereas both the outer and inner medulla are in the middle or below the mitochondrial pO2 range and could be classified as hypoxic. The estimates of inner medulla were based on blood volume and hematocrit estimates in outer medulla (due to lack of literature values). Whether that explains the relative higher values of pO2 requires further investigations.
There are limitations to this approach. The method for converting from MRI-measured parameters (R2, R2*) to physiological ones (SHb and pO2) requires a number of parameters that are regionally inhomogeneous and may not be readily available. This is especially true for changes in these parameters (e.g., regional hematocrit) in response to the pharmacological maneuvers. For example, following L-NAME administration, blood flow decreases and a possible reduction in blood volume may occur as well. Although a reduction in blood flow leads to a decrease in blood oxygenation, normally seen as increased R2*, the corresponding reduction in blood volume would serve to decrease R2*, possibly negating the former effect. Without an independent measure of blood volume, our model is unable to capture such a change, causing us to overestimate blood pO2 following L-NAME. Similarly, changes in these parameters under certain disease states could make comparisons to healthy subjects challenging. The model makes assumptions about blood pH and the corresponding oxygen saturation curve that may not hold under certain disease conditions as well. Additionally, we did not control the water and salt intake of the animals in this preliminary study, which are known to influence R2* (30, 31) .
CONCLUSION
In conclusion, the model for estimating blood pO2 based on BOLD MRI measurements shows promise in its ability to measure baseline pO2 in cortex and outer medulla. The validity of the changes observed following pharmaceutical maneuvers requires further work to compare with an invasive blood pO2 measurement. By taking into account the difference in HCT between the renal cortex and the outer medulla, the large difference in oxygenation between the two regions becomes readily apparent; this is not clear from the relative R2* values (in Fig. 5 ). The conversion of R2 0 to pO2 also allows for the possibility of classifying regional hypoxia. Although there are several parameters that must be taken into account (e.g., blood pH, systemic hematocrit), it may be possible to calibrate these with a blood sample from each subject. By reporting physiological parameters rather than conventional R2* measurements, renal BOLD MRI may find a greater acceptance among physicians and an increased clinical utility.
